• 1
    Shevach EM. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol. 2002; 2: 389400.
  • 2
    Brea D, Sobrino T, Ramos-Cabrer P, et al. Inflammatory and neuroimmunomodulatory changes in acute cerebral ischemia. Cerebrovasc Dis. 2009; 27: 4864.
  • 3
    Yan J, Greer JM, Etherington K, et al. Immune activation in the peripheral blood of patients with acute ischemic stroke. J Neuroimmunol. 2009; 206: 1127.
  • 4
    Emsley HC, Smith CJ, Gavin CM, et al. An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol. 2003; 139: 93101.
  • 5
    Rodríguez-Yáñez M, Castillo J. Role of inflammatory markers in brain ischemia. Curr Opin Neurol. 2008; 21: 3537.
  • 6
    Castillo J, Álvarez-Sabín J, Martínez-Vila E, et al. Inflammation markers and prediction of post-stroke vascular disease recurrence: the MITICO study. J Neurol. 2009; 256: 21724.
  • 7
    Enlimomab Acute Stroke Trial Investigators. Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial. Neurology. 2001; 57: 142834.
  • 8
    Gandolfo MT, Jang HR, Bagnasco SM, et al. Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury. Kidney Int. 2009; 76: 71729.
  • 9
    Feng M, Wang Q, Zhang F, et al. Ex vivo induced regulatory T cells regulate inflammatory response of Kupffer cells by TGF-beta and attenuate liver ischemia reperfusion injury. Int Immunopharmacol. 2012; 12: 18996.
  • 10
    Offner H, Subramanian S, Parker SM, et al. Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J Immunol. 2006; 176: 652331.
  • 11
    Stubbe T, Ebner F, Richter D, et al. Regulatory T cells accumulate and proliferate in the ischemic hemisphere for up to 30 days after MCAO. J Cereb Blood Flow Metab. 2013; 33: 3747.
  • 12
    Ishibashi S, Maric D, Mou Y, et al. Mucosal tolerance to E-selectin promotes the survival of newly generated neuroblasts via regulatory T-cell induction after stroke in spontaneously hypertensive rats. J Cereb Blood Flow Metab. 2009; 29: 60620.
  • 13
    Liesz A, Suri-Payer E, Veltkamp C, et al. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med. 2009; 15: 1929.
  • 14
    Ren X, Akiyoshi K, Vandenbark AA, et al. CD4+FoxP3+ regulatory T-cells in cerebral ischemic stroke. Metab Brain Dis. 2011; 26: 8790.
  • 15
    Kleinschnitz C, Wiendl H. Con: regulatory T cells are protective in ischemic stroke. Stroke. 2013; 44: e878.
  • 16
    Li P, Gan Y, Sun BL, et al. Adoptive regulatory T-cell therapy protects against cerebral ischemia. Annals of neurology. 2013; 74: 45871.
  • 17
    Zouggari Y, Ait-Oufella H, Waeckel L, et al. Regulatory T cells modulate postischemic neovascularization. Circulation. 2009; 120: 141525.
  • 18
    Hellingman AA, van der Vlugt LE, Lijkwan MA, et al. A limited role for regulatory T cells in post-ischemic neovascularization. J Cell Mol Med. 2012; 16: 32836.
  • 19
    Hu X, Li P, Chen J. Pro: regulatory T cells are protective in ischemic stroke. Stroke. 2013; 44: e856.
  • 20
    Schabitz WR. Regulatory T cells in ischemic stroke: helpful or hazardous? Stroke. 2013; 44: e84.
  • 21
    Beyersdorf N, Balbach K, Hunig T, et al. Large-scale expansion of rat CD4+ CD25+ T(reg) cells in the absence of T-cell receptor stimulation. Immunology. 2006; 119: 44150.
  • 22
    Hilchey SP, Bernstein SH. Use of CFSE to monitor ex vivo regulatory T-cell suppression of CD4+ and CD8+ T-cell proliferation within unseparated mononuclear cells from malignant and non-malignant human lymph node biopsies. Immunol Invest. 2007; 36: 62948.
  • 23
    Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989; 20: 8491.
  • 24
    Beyersdorf N, Gaupp S, Balbach K, et al. Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis. J Exp Med. 2005; 202: 44555.
  • 25
    Spoelgen R, Meyer A, Moraru A, et al. A novel flow cytometry-based technique to measure adult neurogenesis in the brain. J Neurochem. 2011; 119: 16575.
  • 26
    Albers GW, Goldstein LB, Hess DC, et al. Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies. Stroke. 2011; 42: 264550.
  • 27
    Stroke Therapy Academic Industry Roundtable (STAIR). Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke. 1999; 30: 27528.